T
60
-3
TSCO
57
-3
AAP
23
2
FIS
51
-2
L
60
2
TAP
53
2
NOC
47
-3
TMO
58
-2
ACN
43
-13
FE
50
-7
PRGO
48
-2
AIV
62
-3
CME
59
-2
CF
57
3
VRTX
60
-3
MO
33
-2
WDC
52
3
HRL
36
-2
PM
56
-8
MOS
20
4
T
60
-3
TSCO
57
-3
AAP
23
2
FIS
51
-2
L
60
2
TAP
53
2
NOC
47
-3
TMO
58
-2
ACN
43
-13
FE
50
-7
PRGO
48
-2
AIV
62
-3
CME
59
-2
CF
57
3
VRTX
60
-3
MO
33
-2
WDC
52
3
HRL
36
-2
PM
56
-8
MOS
20
4
Financhill
Back

Amphastar Pharmaceuticals Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

AMPH
Amphastar Pharmaceuticals

Last Price:
49.83
Seasonality Move:
6.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Chicago Pit Trader Exposes Shocking Trading Advantage:

See How to Target Up to 383% OVERNIGHT

Amphastar Pharmaceuticals Price Quote

$49.83
+1.19 (+2.45%)
(Updated: September 18, 2024 at 6:55 PM ET)

Amphastar Pharmaceuticals Key Stats

Buy
55
Amphastar Pharmaceuticals (AMPH) is a Buy
Day range:
$48.00 - $49.28
52-week range:
$36.56 - $65.92
Dividend yield:
0%
P/E ratio:
18.71
P/S ratio:
3.62
P/B ratio:
3.34%
Volume:
290.2K
Avg. volume:
374.2K
1-year change:
6.27%
Market cap:
$2.4B
Revenue:
$644.4M
EPS:
$3.13

How Much Does Amphastar Pharmaceuticals Make?

Is Amphastar Pharmaceuticals Growing As A Company?

Amphastar Pharmaceuticals Stock Price Performance

What Is Amphastar Pharmaceuticals 52-Week High & Low?

Amphastar Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Amphastar Pharmaceuticals?

Is Amphastar Pharmaceuticals Cash Flow Positive?

  • What Is AMPH Cash Flow From Operations?
    Cash flow from operations (TTM) is $212.6M
  • What Is Amphastar Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $15.2M
  • What Is Amphastar Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$188.9M

Amphastar Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AMPH return on invested capital is 13.6%
  • What Is Amphastar Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 11.1%
  • What Is AMPH Return On Equity?
    ROE is a measure of profitability and is 25.94%

Amphastar Pharmaceuticals Earnings Date & Stock Price

Amphastar Pharmaceuticals Competitors

Amphastar Pharmaceuticals Dividend Yield

Amphastar Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 48.98% 25.08%
Revenue: 25.17% 6.72%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 59.80
Upside from Last Price: 22.94%

Major Shareholders

  • How many AMPH shares are owned by institutional investors?
    57.3M AMPH shares are owned by institutional investors
  • How many AMPH shares are owned by insiders?
    1.1M AMPH shares are owned by insiders